Five studies, one question: are we overlooking hidden drivers of health?
By:
Teraya Smith
Conexiant June 25, 2026
4 Topic Commentaries
Medical Oddities: Could GLP-1s Curb Violence?
Daniel C. Semenza, PhD
Criminology and Public Health
•
Rutgers University
As GLP-1 drugs become increasingly widespread, it is important to understand all of their potential behavioral effects, including those relevant to public safety.
Our findings are consistent with these medications working like cognitive behavioral therapy, weakening the path from impulse to action rather than eliminating impulsivity itself.
Bio:Teraya Smith is an author for Conexiant covering neurology-related medical news and research updates. Her work includes reporting on emerging findings in brain health and other notable developments from medical journals.
4 Topic Commentaries
Medical Oddities: Could GLP-1s Curb Violence?
Daniel C. Semenza, PhD
Criminology and Public Health
•Rutgers University
Christopher Thomas, PhD
Criminal Justice and Criminology
•Rutgers University–Camden
Ali D. Güler, PhD
Neuroscience
•University of Virginia
Lorenzo Leggio and Leandro F. Vendruscolo, Lorenzo Leggio, MD, PhD; Leandro F. Vendruscolo, PharmD, PhD
Addiction Medicine and Addiction Neuroscience
•National Institute on Alcohol Abuse and Alcoholism (NIAAA) and National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.